ALX Oncology

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO

Jaume Pons

CEOJaume Pons

Employees

Employees43

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees43

ALXO Key Statistics

Market cap

427.84M

Market cap427.84M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

144.28K

Average volume144.28K

High today

$10.75

High today$10.75

Low today

$9.94

Low today$9.94

Open price

$9.94

Open price$9.94

Volume

186.87K

Volume186.87K

52 Week high

$76.15

52 Week high$76.15

52 Week low

$5.82

52 Week low$5.82

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

ALXO Earnings

-$0.67

-$0.45

-$0.22

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours